PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
XPH vs. PJP
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Performance

XPH vs. PJP - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in SPDR S&P Pharmaceuticals ETF (XPH) and Invesco Dynamic Pharmaceuticals ETF (PJP). The values are adjusted to include any dividend payments, if applicable.

0.00%5.00%10.00%15.00%20.00%JuneJulyAugustSeptemberOctoberNovember
16.74%
10.06%
XPH
PJP

Returns By Period

In the year-to-date period, XPH achieves a 13.28% return, which is significantly lower than PJP's 14.68% return. Over the past 10 years, XPH has underperformed PJP with an annualized return of 0.05%, while PJP has yielded a comparatively higher 4.07% annualized return.


XPH

YTD

13.28%

1M

0.74%

6M

16.74%

1Y

28.75%

5Y (annualized)

4.27%

10Y (annualized)

0.05%

PJP

YTD

14.68%

1M

-0.39%

6M

10.06%

1Y

24.55%

5Y (annualized)

8.08%

10Y (annualized)

4.07%

Key characteristics


XPHPJP
Sharpe Ratio1.711.91
Sortino Ratio2.462.58
Omega Ratio1.291.32
Calmar Ratio0.771.59
Martin Ratio4.4411.03
Ulcer Index6.47%2.23%
Daily Std Dev16.83%12.86%
Max Drawdown-48.03%-37.06%
Current Drawdown-19.04%-3.29%

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


XPH vs. PJP - Expense Ratio Comparison

XPH has a 0.35% expense ratio, which is lower than PJP's 0.58% expense ratio.


PJP
Invesco Dynamic Pharmaceuticals ETF
Expense ratio chart for PJP: current value at 0.58% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%0.58%
Expense ratio chart for XPH: current value at 0.35% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%0.35%

Correlation

-0.50.00.51.00.9

The correlation between XPH and PJP is 0.87, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.

Risk-Adjusted Performance

XPH vs. PJP - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for SPDR S&P Pharmaceuticals ETF (XPH) and Invesco Dynamic Pharmaceuticals ETF (PJP). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for XPH, currently valued at 1.71, compared to the broader market0.002.004.001.711.91
The chart of Sortino ratio for XPH, currently valued at 2.46, compared to the broader market-2.000.002.004.006.008.0010.0012.002.462.58
The chart of Omega ratio for XPH, currently valued at 1.29, compared to the broader market0.501.001.502.002.503.001.291.32
The chart of Calmar ratio for XPH, currently valued at 0.77, compared to the broader market0.005.0010.0015.0020.000.771.59
The chart of Martin ratio for XPH, currently valued at 4.44, compared to the broader market0.0020.0040.0060.0080.00100.004.4411.03
XPH
PJP

The current XPH Sharpe Ratio is 1.71, which is comparable to the PJP Sharpe Ratio of 1.91. The chart below compares the historical Sharpe Ratios of XPH and PJP, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Rolling 12-month Sharpe Ratio-0.500.000.501.001.502.002.503.00JuneJulyAugustSeptemberOctoberNovember
1.71
1.91
XPH
PJP

Dividends

XPH vs. PJP - Dividend Comparison

XPH's dividend yield for the trailing twelve months is around 1.50%, more than PJP's 0.89% yield.


TTM20232022202120202019201820172016201520142013
XPH
SPDR S&P Pharmaceuticals ETF
1.50%1.28%1.64%0.95%0.47%0.64%0.65%0.67%0.63%7.15%5.55%2.06%
PJP
Invesco Dynamic Pharmaceuticals ETF
0.89%1.01%0.95%0.81%0.76%0.77%1.11%0.65%0.91%5.49%2.96%0.44%

Drawdowns

XPH vs. PJP - Drawdown Comparison

The maximum XPH drawdown since its inception was -48.03%, which is greater than PJP's maximum drawdown of -37.06%. Use the drawdown chart below to compare losses from any high point for XPH and PJP. For additional features, visit the drawdowns tool.


-35.00%-30.00%-25.00%-20.00%-15.00%-10.00%-5.00%0.00%JuneJulyAugustSeptemberOctoberNovember
-19.04%
-3.29%
XPH
PJP

Volatility

XPH vs. PJP - Volatility Comparison

SPDR S&P Pharmaceuticals ETF (XPH) has a higher volatility of 5.51% compared to Invesco Dynamic Pharmaceuticals ETF (PJP) at 4.74%. This indicates that XPH's price experiences larger fluctuations and is considered to be riskier than PJP based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


2.00%3.00%4.00%5.00%6.00%JuneJulyAugustSeptemberOctoberNovember
5.51%
4.74%
XPH
PJP